Distributed sensor networks for detection of mobile radioactive sources von Nemzek, R.J., Dreicer, J.S., Torney, D.C., Warnock, T.T.

Volltext

Distributed sensor network with collective computation for situational awareness von Dreicer, J S, Jorgensen, A M, Dors, E E

Volltext

Infrastructure Modeling: Status and Applications von Leclaire, R. J., Pasqualini, D., Dreicer, J. S., Toole, G. L., Urban, N. M., Bent, R. W., Mcpherson, T. N., Hengartner, N. W.

Volltext

Continuous monitoring of a capacitor bank von Mielke, A.M., Boyle, C.M., Buenafe, C.A., Dreicer, J.S., Gattiker, J.R., Martinez, B.J., Smith, D.A.

Volltext

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer von Sweeney, Christopher J, Chen, Yu-Hui, Carducci, Michael, Liu, Glenn, Jarrard, David F, Eisenberger, Mario, Wong, Yu-Ning, Hahn, Noah, Kohli, Manish, Cooney, Matthew M, Dreicer, Robert, Vogelzang, Nicholas J, Picus, Joel, Shevrin, Daniel, Hussain, Maha, Garcia, Jorge A, DiPaola, Robert S

Volltext

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial von Kyriakopoulos, Christos E, Chen, Yu-Hui, Carducci, Michael A, Liu, Glenn, Jarrard, David F, Hahn, Noah M, Shevrin, Daniel H, Dreicer, Robert, Hussain, Maha, Eisenberger, Mario, Kohli, Manish, Plimack, Elizabeth R, Vogelzang, Nicholas J, Picus, Joel, Cooney, Matthew M, Garcia, Jorge A, DiPaola, Robert S, Sweeney, Christopher J

Volltext

Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma von Galsky, M.D., Chen, G.J., Oh, W.K., Bellmunt, J., Roth, B.J., Petrioli, R., Dogliotti, L., Dreicer, R., Sonpavde, G.

Volltext

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial von Balar, Arjun V, Dr, Galsky, Matthew D, MD, Rosenberg, Jonathan E, MD, Powles, Thomas, MD, Petrylak, Daniel P, MD, Bellmunt, Joaquim, MD, Loriot, Yohann, MD, Necchi, Andrea, MD, Hoffman-Censits, Jean, MD, Perez-Gracia, Jose Luis, MD, Dawson, Nancy A, MD, van der Heijden, Michiel S, MD, Dreicer, Robert, MD, Srinivas, Sandy, MD, Retz, Margitta M, MD, Joseph, Richard W, MD, Drakaki, Alexandra, MD, Vaishampayan, Ulka N, MD, Sridhar, Srikala S, MD, Quinn, David I, MD, Durán, Ignacio, MD, Shaffer, David R, MD, Eigl, Bernhard J, MD, Grivas, Petros D, MD, Yu, Evan Y, MD, Li, Shi, PhD, Kadel, Edward E, BS, Boyd, Zachary, MSc, Bourgon, Richard, PhD, Hegde, Priti S, PhD, Mariathasan, Sanjeev, PhD, Thåström, AnnChristine, PhD, Abidoye, Oyewale O, MD, Fine, Gregg D, MD, Bajorin, Dean F, MD

Volltext

Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer von Sartor, Oliver, de Bono, Johann, Chi, Kim N, Fizazi, Karim, Herrmann, Ken, Rahbar, Kambiz, Tagawa, Scott T, Nordquist, Luke T, Vaishampayan, Nitin, El-Haddad, Ghassan, Park, Chandler H, Beer, Tomasz M, Armour, Alison, Pérez-Contreras, Wendy J, DeSilvio, Michelle, Kpamegan, Euloge, Gericke, Germo, Messmann, Richard A, Morris, Michael J, Krause, Bernd J

Volltext

Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials W... von SCHER, Howard I, HALABI, Susan, PETRYLAK, Daniel, KANTOFF, Philip, BASCH, Ethan, KELLY, William Kevin, FIGG, William D, SMALL, Eric J, BEER, Tomasz M, WILDING, George, MARTIN, Alison, HUSSAIN, Maha, TANNOCK, Ian, MORRIS, Michael, STERNBERG, Cora N, CARDUCCI, Michael A, EISENBERGER, Mario A, HIGANO, Celestia, BUBLEY, Glenn J, DREICER, Robert

Volltext

Phase 1/2 multiple ascending dose trial of the prostate-specific membrane antigen-targeted antibody drug conjugate MLN2704 in metastatic castration-resistant prostate cancer von Milowsky, Matthew I., M.D, Galsky, Matthew D., M.D, Morris, Michael J., M.D, Crona, Daniel J., Pharm.D., Ph.D, George, Daniel J., M.D, Dreicer, Robert, M.D, Tse, Kin, B.S, Petruck, Jesika, B.S, Webb, Iain J., M.D, Bander, Neil H., M.D, Nanus, David M., M.D, Scher, Howard I., M.D

Volltext

Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-... von Saad, Fred, Dr Prof, Fizazi, Karim, Prof, Jinga, Viorel, Prof, Efstathiou, Eleni, MD, Fong, Peter C, MD, Hart, Lowell L, MD, Jones, Robert, MD, McDermott, Raymond, MD, Wirth, Manfred, Prof, Suzuki, Kazuhiro, Prof, MacLean, David B, MD, Wang, Ling, PhD, Akaza, Hideyuki, Prof, Nelson, Joel, Prof, Scher, Howard I, Prof, Dreicer, Robert, Prof, Webb, Iain J, MD, de Wit, Ronald, Prof

Volltext

Prospective Clinical Study of Precision Oncology in Solid Tumors von Sohal, Davendra P S, Rini, Brian I, Khorana, Alok A, Dreicer, Robert, Abraham, Jame, Procop, Gary W, Saunthararajah, Yogen, Pennell, Nathan A, Stevenson, James P, Pelley, Robert, Estfan, Bassam, Shepard, Dale, Funchain, Pauline, Elson, Paul, Adelstein, David J, Bolwell, Brian J

Volltext

ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for Urothelial Carcinoma—Neoadjuvant and Adjuvant Settings von Sternberg, Cora N, Bellmunt, Joaquim, Sonpavde, Guru, Siefker-Radtke, Arlene O, Stadler, Walter M, Bajorin, Dean F, Dreicer, Robert, George, Daniel J, Milowsky, Matthew I, Theodorescu, Dan, Vaughn, David J, Galsky, Matthew D, Soloway, Mark S, Quinn, David I

Volltext

Phase 1 study of PSMA ADC, an antibody‐drug conjugate targeting prostate‐specific membrane antigen, in chemotherapy‐refractory prostate cancer von Petrylak, Daniel P., Kantoff, Philip, Vogelzang, Nicholas J., Mega, Anthony, Fleming, Mark T., Stephenson, Joe J., Frank, Richard, Shore, Neal D., Dreicer, Robert, McClay, Edward F., Berry, William R., Agarwal, Manish, DiPippo, Vincent A., Rotshteyn, Yakov, Stambler, Nancy, Olson, William C., Morris, Stephen A., Israel, Robert J.

Volltext

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3 von Scher, Howard I, Morris, Michael J, Stadler, Walter M, Higano, Celestia, Basch, Ethan, Fizazi, Karim, Antonarakis, Emmanuel S, Beer, Tomasz M, Carducci, Michael A, Chi, Kim N, Corn, Paul G, de Bono, Johann S, Dreicer, Robert, George, Daniel J, Heath, Elisabeth I, Hussain, Maha, Kelly, Wm Kevin, Liu, Glenn, Logothetis, Christopher, Nanus, David, Stein, Mark N, Rathkopf, Dana E, Slovin, Susan F, Ryan, Charles J, Sartor, Oliver, Small, Eric J, Smith, Matthew Raymond, Sternberg, Cora N, Taplin, Mary-Ellen, Wilding, George, Nelson, Peter S, Schwartz, Lawrence H, Halabi, Susan, Kantoff, Philip W, Armstrong, Andrew J

Volltext

A 2 weeks on and 1 week off schedule of sunitinib is associated with decreased toxicity in metastatic renal cell carcinoma von Najjar, Y.G, Mittal, K, Elson, P, Wood, L, Garcia, J.A, Dreicer, R, Rini, B.I

Volltext

Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer von Li, Zhenfei, Bishop, Andrew C., Alyamani, Mohammad, Garcia, Jorge A., Dreicer, Robert, Bunch, Dustin, Liu, Jiayan, Upadhyay, Sunil K., Auchus, Richard J., Sharifi, Nima

Volltext

Chronic kidney disease after nephroureterectomy for upper tract urothelial carcinoma and implications for the administration of perioperative chemotherapy von Lane, Brian R., Smith, Armine K., Larson, Benjamin T., Gong, Michael C., Campbell, Steven C., Raghavan, Derek, Dreicer, Robert, Hansel, Donna E., Stephenson, Andrew J.

Volltext

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer von Kantoff, Philip W, Higano, Celestia S, Shore, Neal D, Berger, E. Roy, Small, Eric J, Penson, David F, Redfern, Charles H, Ferrari, Anna C, Dreicer, Robert, Sims, Robert B, Xu, Yi, Frohlich, Mark W, Schellhammer, Paul F

Volltext